Leases (Details Narrative) - Sonnet BioTherapeutics Holdings, Inc. [Member] - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Sep. 30, 2024 |
Dec. 31, 2019 |
|
| Lease term | 36 months | |
| Increase in operating lease right of use asset | $ 0.2 | |
| Increase in operating lease liability | $ 0.2 | |
| Weighted-average remaining lease term | 1 year 7 months 6 days | |
| Weighted average discount rate | 12.00% |
| X | ||||||||||
- Definition Increase decrease in operating lease right of use asset. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in obligation for operating lease. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average discount rate for operating lease calculated at point in time. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|